Primary Site >> Esophagus Cancer

Gene >> IGF2BP3

  • 2007
  • 2012
  • 2014
Ref: Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.
PMID: 17784873
Ref: Identification of unique expression signatures and therapeutic targets in esophageal squamous cell carcinoma.
PMID: 22280838
Ref: Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.
PMID: 22776426
Ref: Identification of insulin-like growth factor 2 mRNA-binding protein 3 as a radioresistance factor in squamous esophageal cancer cells.
PMID: 22989274
Ref: Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients.
PMID: 24708624
Ref: Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
PMID: 24761876